Contact
Please use this form to send email to PR contact of this press release:
Oasmia Pharmaceutical Announces Enrollment of First Patient in Clinical Study with Docecal, a Novel Formulation of Docetaxel
TO:
Please use this form to send email to PR contact of this press release:
Oasmia Pharmaceutical Announces Enrollment of First Patient in Clinical Study with Docecal, a Novel Formulation of Docetaxel
TO: